Related Experiment Video

Updated: May 27, 2026

Investigations on Alterations of Hippocampal Circuit Function Following Mild Traumatic Brain Injury
10:59

Investigations on Alterations of Hippocampal Circuit Function Following Mild Traumatic Brain Injury

Published on: November 19, 2012

Contribution of hyperammonemia and inflammatory factors to cognitive impairment in minimal hepatic encephalopathy

Vicente Felipo1, Amparo Urios, Encarna Montesinos

  • 1Laboratory of Neurobiology. Centro de Investigación Príncipe Felipe, Valencia, Spain.

Metabolic Brain Disease
|November 11, 2011
PubMed

Insights

High ammonia and inflammation levels, not liver disease, can cause cognitive impairment. This combination, even without liver issues, is sufficient to induce cognitive impairment (CI).

Area of Science:

  • Medical Science
  • Neuroscience
  • Immunology

Background:

  • Mild cognitive impairment (MCI) is often associated with liver disease.
  • The specific roles of hyperammonemia and inflammation in cognitive impairment require further elucidation.

Purpose of the Study:

  • To investigate the independent and combined contributions of hyperammonemia and inflammation to the development of mild cognitive impairment (MCI).

Main Methods:

  • Assessed cognitive impairment (CI) using the PHES psychometric test battery.
  • Measured blood ammonia, IL-6, and IL-18 levels in patients with various liver and dermatological conditions.
  • Included patient groups with liver cirrhosis, NAFLD, NASH, psoriasis, keloids, and healthy controls.

Main Results:

  • Cognitive impairment was observed in patients with NASH and keloids, linked to both hyperammonemia and inflammation.
  • Neither hyperammonemia nor inflammation alone induced cognitive impairment.
  • A combination of sufficient hyperammonemia and inflammation levels was sufficient to cause CI, irrespective of liver disease presence.

Conclusions:

  • The synergistic effect of hyperammonemia and inflammation, rather than liver disease alone, is a key driver of cognitive impairment.
  • Cognitive impairment can manifest in conditions beyond liver disease if hyperammonemia and inflammation are significantly elevated.
  • Early identification and management of hyperammonemia and inflammation may be crucial for preventing cognitive decline.

More Related Videos

Using Enzyme-based Biosensors to Measure Tonic and Phasic Glutamate in Alzheimer's Mouse Models10:46

Using Enzyme-based Biosensors to Measure Tonic and Phasic Glutamate in Alzheimer's Mouse Models

Published on: May 3, 2017

Related Concept Videos

Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...